Recent advancements in multiplexed profiling and tissue imaging methods have enabled the assessment of spatial heterogeneity in intact tissues; as a result, adoption of spatial omics solutions offering benefits over traditional methods, is increasing
Roots Analysis has announced the addition of “Spatial Genomics, Transcriptomics and Proteomics Solutions Market, 2022-2035” report to its list of offerings.
The Spatial Genomics Market report features an extensive study of the current market landscape and the likely future potential; associated with the spatial omics solutions market, over the next decade. The study also includes a detailed analysis of key drivers and trends within this evolving market. Amongst other elements, the report features:
A detailed overview of the overall market landscape of spatial omics solutions based on several relevant parameters.
A detailed overview of the overall market landscape of players engaged in offering spatial proteomics, transcriptomics and genomics solutions, based on year of establishment, company size, location of headquarters and regional landscape.
A detailed competitiveness analysis of products based on parameters, such as supplier power and product specifications.
Elaborate profiles of key players offering spatial omics solutions.
An analysis of the various partnerships related to spatial omics solutions inked by players engaged in this domain.
An in-depth analysis of patents related to spatial omics solutions, filed / granted, since 2003.
A detailed review of around 600 peer-reviewed, scientific articles related to research on spatial omics solutions.
An elaborate discussion on the various commercialization strategies that can be adopted by drug developers engaged in this domain, across different stages of therapy development, including prior to drug launch, at / during drug launch and post-marketing of the drug.
A detailed review of the overall landscape of the live cell instruments market, highlighting the contributions of industry players, along with information on their year of establishment, company size, geographical location of headquarters, ownership and instruments specific parameters.
A detailed review of the overall landscape of sequencing technologies market, highlighting the contributions of industry players, along with information on their year of establishment, company size, geographical location of headquarters, ownership and sequencers specific parameters.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of Solution
Instruments
Consumables
Services
Sample Type
DNA
RNA
Protein
Research Area
Oncological Disorders
Immunological Disorders
Neurological Diorders
Infectious Diseases
Others
End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Key Geographical Regions
North America
Europe
Asia-Pacific and Rest of the World
Key companies covered in the report
10x Genomics
Akoya Biosciences
Bruker
Canopy Biosciences
NanoString Technologies
Vizgen
Lunaphore Technologies
Molecular Machines & Industries (MMI)
Resolve Biosciences
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/spatial-genomics-market.html
You may also be interested in the following titles:
Cannabis Testing Market
Decentralized Clinical Trials / Virtual Clinical Trials Market
You may also like to learn what our experts are sharing in Roots educational series:
At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector
SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Posts
Roots Analysis has done a detailed study on Gene Switch Market, 2023-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
Key Market Insights
Presently, close to 50 gene switch platforms are being developed for various applications in adoptive cell therapies (ACT), including CAR-Ts, TCRs and gene therapies; majority of them are protein-based gene switches
Various small molecules, including rimiducid, rapamycin and dasatinib, are being investigated to design safety switch for ACTs; management of treatment related toxicity has emerged as the key application of such platforms
The current market landscape is fragmented, featuring the presence of both new entrants and established players; presently, majority of the gene switch platform developers are based in North America
In pursuit of gaining a competitive edge, gene switch developers are presently undertaking several initiatives to expand their existing capabilities and augment respective product portfolios
The growing interest in this domain is evident from the rise in licensing agreements over the last few years; majority of such deals were signed between players based in North America
Several investors, having realized the opportunity within this domain, have invested over USD 3.5 billion across various funding rounds in the past five years
Scientific articles being published for gene switch, reflect the growing research efforts of various industry and academic stakeholders; majority of the authors are affiliated to organizations based in North America
More than 360 patents have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field since 2014
Based on historical trends, we expect a steady growth in the licensing of gene switch platforms, in order to meet the growing demand for safe and effective gene therapies
The gene switch market is expected to grow at a CAGR of 11.5% till 2035; the overall opportunity is anticipated to be well distributed across various segments, such as types of target therapies, application areas and key regions
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Key Questions Answered
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Emergence of Gene Switch
3.3. Applications of Gene Switch
3.4. Challenges Associated with Gene Switch
3.5. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Gene Switch Platforms: Overall Market Landscape
4.3. Gene Switch Platform Developers: Developer Landscape
5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis: Gene Switch Platforms
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. aceRNA Technologies
6.2.1. Company Overview
6.2.2. Gene Switch Platform Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Autolus Therapeutics
6.4. Bellicum Pharmaceuticals
6.5. Cellectis
6.6. Kiromic BioPharma
6.7. panCELLa
6.8. Precigen
6.9. Sana Biotechnology
6.10. Sangamo Therapeutics
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Gene Switch Platforms: Partnerships and Collaborations
8. FUNDING AND INVESTMENT ANALYSIS
8.1. Chapter Overview
8.2. Type of Funding
8.3. Gene Switch Platforms: Funding and Investments Analysis
9. PUBLICATION ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Gene Switch Platforms: Recent Publications
10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Gene Switch Platforms: Patent Analysis
10.4. Gene Switch Platforms: Patent Benchmarking Analysis
10.5. Gene Switch Platforms: Patent Valuation
10.6. Leading Patents: Analysis by Number of Citations
11. BUSINESS MODEL ANALYSIS
11.1. Chapter Overview
11.2. Gene Switch Platform Developers: Business Model Analysis
11.3. Concluding Remarks
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Global Gene Switch Platform Market, 2023-2035
13. CONCLUDING REMARKS
14. APPENDIX 1: TABULATED DATA
15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/gene-switch-market.html
Learn from experts: do you know about these emerging industry trends?
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Medical Device Coatings and Modification Technologies
Learn from our recently published whitepaper:-
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical and Biotechnology Market (3rd Edition), 2023-2035” report to its list of offerings.
Key Market Insights
Presently, over 50 modular facility providers are engaged in the healthcare market, located across the globe
Currently, more than 250 modular cleanroom providers are offering controlled environments along with accessories in the healthcare domain
The partnership activity for modular facilities in healthcare domain has grown at a CAGR of over 30%, in the past three years, 2018-2021
The projected future opportunity for companies engaged in this field is expected to be well distributed across size of facility, type of industry served, type of modular construct, type of construction component, purpose of facility, scale of operation, type of product, type of expansion, type of modular construction, type of material used and key geographical regions.
An insightful competitiveness analysis of players involved in the modular facilities manufacturing in the healthcare domain
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process
3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects
4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
5. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS
5.1. Chapter Overview
5.2. Modular Cleanroom Providers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained
6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook
7.3. G-Con Manufacturing
7.4. Germfree
7.5. IPM Technologies
7.6. KeyPlants
7.7. ModuleCo Pharma
7.8. NNE
7.9. Pharmadule
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country
9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.3.1. Analysis by Type of Modular Facility
9.3.2. Analysis by Size of Modular Facility
9.3.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.3.4. Most Active Clients: Analysis by Number of Projects Received
9.3.5. Analysis by Location of Modular Facility
9.3.6. Analysis by Type of Facility and Size of Modular Facility
9.3.7. Analysis by Client and Location of Facility
10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility
11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Factors Influencing Modular Construction
11.3.1. Intrinsic Factors
11.3.2. Extrinsic Factors
11.4. Cost Efficiency Analysis
11.5. Time-Benefit Analysis
11.6. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector,
2023-2035
12.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-203
12.4.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035
12.4.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035
12.4.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035
12.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Facilities Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Facilities Market in the Biotechnology Industry, 2023-2035
12.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035
12.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035
12.7.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Buildings, 2023-2035
12.7.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035
12.7.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035
12.8 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing, 2023-2035
12.8.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling, 2023-2035
12.8.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development, 2023-2035
12.8.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Purposes, 2023-2035
12.9. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Scale, 2023-2035
12.9.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Scale, 2023-2035
12.10. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035
12.10.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035
12.10.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035
12.10.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035
12.10.8. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035
12.11. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035
12.11.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035
12.11.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035
12.12. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035
12.13. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035
12.13.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035
12.13.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035
12.14. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Geography, 2023 and 2035
12.14.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035
12.14.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035
12.14.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035
12.14.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035
12.14.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World,
2023-2035
12.15. Concluding Remaks
13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions
15. CONCLUSION
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.2. Interview Transcript: Alan de Zayas (Modular Building Manufacturing and Construction Team)
16.3. Environmental Systems Corporation
16.3.2. Interview Transcript: Vernon Solomon (President)
16.4. Exyte
16.4.2. Interview Transcript: François Abiven (Executive Vice President Global Business Unit BLS) and Luca Mussati (Vice President Technology and Innovation)
16.5. G-Con Manufacturing
16.5.2. Interview Transcript: Maik Jornitz (Chief Executive Officer)
16.6. Modular Devices
16.6.2. Interview Transcript: Mark Koers (Executive Vice President, Sales and Marketing)
16.7. ModWave
16.7.2. Interview Transcript: Pär Almhem (President)
16.8. Subzero Engineering
16.8.2. Interview Transcript: Ward Patton (Director of Sales)
16.9. Vernick
16.9.2. Interview Transcript: Wes Temple (Director of Marketing)
16.10. Zeton
16.10.2. Interview Transcript: Sulogna Roy (Ex-Sales Manager)
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html
You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market
Gene Switch Market
You may also like to learn what our experts are sharing in Roots educational series:
Digital Therapies: The “Digital Pills” of current generation
Medical Device Coatings and Modification Technologies
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Roots Analysis has done a detailed study on “AI-based Digital Pathology Market, 2022-2035”, covering key aspects of the market’s evolution and identifying potential future growth opportunities.
Key Market Insights
Presently, close to 80 players offering AI-based digital pathology services are available in the healthcare market which are located across the globe
In order to tap into the lucrative opportunity associated with AI-based digital pathology, various investment firms have invested over USD 1.7 billion in AI-based digital pathology market space, during the period 2016-2022
The estimated global demand for AI-based digital pathology is expected to grow at a CAGR of 9,4%, during 2022-2035
The projected future opportunity for companies engaged in this field is expected to be well distributed across different types of neural networks, types of assay, end-users, areas of applications, target disease indications, and key geographical regions
Table of Contents
1. PREFACE
1.1. Chapter Overview
1.2. Market Segmentations
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Artificial Intelligence in Digital Pathology
3.3. Workflow of AI-based Digital Pathology
3.4. Applications of AI-based Digital Pathology Solutions
3.5. Regulatory Requirements Focused on AI-based Digital Pathology:
3.6. Challenges Associated with the Use of AI in Digital Pathology
3.7. Future Perspectives
4. AI-BASED DIGITAL PATHOLOGY: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. AI-based Digital Pathology Providers: Developers Landscape
4.3. AI-based Digital Pathology Providers: Market Landscape
5. AI-BASED DIGITAL PATHOLOGY MARKET: KEY INSIGHTS
5.1. Chapter Overview
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. PathAI
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. Paige
6.4. Akoya Biosciences
6.5. PROSCIA
6.6. Visiopharm
6.7. Roche Tissue Diagnostics
6.8. Aiforia Technologies
6.9. Indica Labs
6.10. Ibex Medical Analytics
7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Benchmarking of Portfolio Strength
7.5. Benchmarking of Funding Strength
7.6. Company Competitiveness Analysis: Small Players
7.7. Company Competitiveness Analysis: Mid-sized Players
7.8. Company Competitiveness Analysis: Large Players
8. FUNDING AND INVESTMENTS
8.1. Chapter Overview
8.2. Types of Funding
8.3. AI-based Digital Pathology: List of Funding and Investments
8.4. Concluding Remarks
9. DEMAND ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Global Demand for AI-based Digital Pathology, 2022-2035
9.4. Demand for AI-based Digital Pathology: Analysis by Geography
9.5. Demand for AI-based Digital Pathology: Analysis by Type of End-user
9.6. Concluding Remarks
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global AI-based Digital Pathology Market, 2022-2035
10.4. AI-based Digital Pathology Market: Analysis by Type of Neural Network, 2022 and 2035
10.5. AI-based Digital Pathology Market: Analysis by Type of Assay, 2022 and 2035
10.6. AI-based Digital Pathology Market: Analysis by Type of End-user, 2022 and 2035
10.7. AI-based Digital Pathology Market: Analysis by Area of Application, 2022 and 2035
10.8. AI-based Digital Pathology Market: Analysis by Target Disease Indication, 2022 and 2035
10.9. AI-based Digital Pathology Market: Analysis by Key Geographies, 2022 and 2035
11. CONCLUDING REMARKS
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. aetherAI
12.3. CTL Clinitech Lab
12.4. Huron Digital Pathology
12.5. Mindpeak
12.6. Pramana
13. APPENDIX 1: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/ai-based-digital-pathology-market.html
Learn from experts: do you know about these emerging industry trends?
TIL Therapies: A New Paradigm in Cancer Treatment
Viral Clearance and Viral Testing Services
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
The new market report titled “Opportunities in the RNA Therapeutics Market”, published by Roots Analysis is one of the most sought-after solutions for investors operating in the RNA therapeutics market.
The report will help investors stay updated with the latest market trends and opportunities associated with the RNA therapeutics market. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, innovator and product landscape, company health indexing, value proposition analysis, company competitiveness, funding and investment, financial analysis of public ventures, business risk analysis, returns on investment and key acquisition targets, as well as the emerging market trends and opportunities in RNA therapeutics market. The opportunities in the RNA therapeutics market are anticipated to expand significantly.
However, the latest report is mainly intended for business leaders, experts, thought leaders, investors, start-ups and growth stage firms interested in RNA Therapeutics business space and is available in the form of PDF and spreadsheet.
Investor Series: Opportunities in the RNA Therapeutics Market:
Investor Series Scope and Market Size:
The report provides detailed information on the RNA therapeutics market, covering the core and peripheral RNA therapeutics solutions. It offers a technical and financial perspective on how the RNA therapeutics market opportunities is likely to evolve, in terms of future business success, over the coming decade. The RNA therapeutics market is broadly segmented on the basis of type of solution, type of therapy, therapeutic area and geographical regions. The segmental growth helps the investors, firms, business leaders to get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the RNA therapeutics market in terms of market size & volume and significant information pertaining to product bifurcation and RNA therapeutics solutions overview.
Key Market Contenders:
This particular section of the RNA therapeutics market report covers all the necessary details of the RNA therapeutics’ solutions developed by players operating in the RNA therapeutics market. The report goes on to elucidate a quantitative perspective on the relative health of the different innovator companies and an assessment of the various solutions, offered by the companies developing DTx solutions, featuring analysis based on number and types of products, and an informed perspective on the value of the offerings based on multiple relevant aspects.
Information on the funding and investment activity that has taken place in this domain since 2011 has also been included in this report. Moreover, the exhaustive report presents financing category-wise trends, describing the relative maturity of the innovator companies. Further, RNA therapeutics market features a list of the leading RNA therapeutics investors , based on their participation in financing activity in this industry segment. It also covers an elaborate review of the overall RNA therapeutics market from a financial perspective, including detailed fundamental (insights from the balance sheet, and key financial ratios) and technical analyses (insights from historical and recent stock price variations, and analysis using popular stock performance indicators) of financial data of the publicly listed companies.
This section of RNA therapeutics market report focusing on the competitive terrain of the RNA therapeutics market endows the reader with every significant detail and information about the leading competitors on the market. The report provides a key acquisition targets analysis, highlighting some of the promising early-to-mid stage business ventures around which there is likely to be interest for future acquisitions / mergers and also includes the case study of instances where investors have exited various RNA therapeutics related ventures, offering insights on return on investments made. Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the RNA therapeutics market.
Section covered in RNA therapeutics market report:
Section 01: Need for RNA Therapeutics and Innovators Landscape
Section 02: Analysis of Investments
Section 03: Financial Analysis and Assessment of Business Risks
Section 04: Market Forecast and Opportunity Analysis
Section 05: Analysis of Returns on Investment and Key Acquisition Targets
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/opportunities-in-RNA-therapeutics-market.html
You may also be interested in the following titles:
Oral Solid Dosage Manufacturing Market
Lipid Nanoparticles in Drug Delivery
You may also like to learn what our experts are sharing in Roots educational series:
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Recent Posts
Roots Analysis has done a detailed study on “AI-ba...
The “Global Bioreactors and Fermenters Market, 202...
Roots Analysis has done a detailed study on Gene S...
Roots Analysis has done a detailed study on “Cell ...